A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Mycobacterium Avium-intracellulare InfectionHIV Infections
Interventions
DRUG

Ethambutol hydrochloride

DRUG

Clarithromycin

DRUG

Azithromycin

Trial Locations (24)

20007

Georgetown Univ Med Ctr, Washington D.C.

20009

Whitman - Walker Clinic, Washington D.C.

23666

Hampton Roads Med Specialists, Hampton

27710

Duke Univ Med Ctr, Durham

30327

West Paces Clinical Research Inc, Atlanta

33125

Med Service, Miami

33609

Bay Area AIDS Consortium, Tampa

33713

Dr Robert Wallace, St. Petersburg

60611

Northwestern Univ Med School, Chicago

60640

Dr Neel French / Louis A Weiss Memorial Hosp, Chicago

64108

Trinity Lutheran Hosp / Infectious Disease Clinic, Kansas City

70121

Oschner Clinic, New Orleans

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

77009

Thomas Street Clinic / Baylor College of Medicine, Houston

77027

Dr Gary Brewton, Houston

78705

Austin Infectious Disease Consultants, Austin

78751

Central Texas Med Foundation, Austin

92668

UCI Med Ctr, Orange

94115

Kaiser Permanente Med Ctr, San Francisco

94609

Infectious Disease Med Group / Adult Immunology Clinic, Oakland

94705

East Bay AIDS Ctr, Berkeley

94941

Dr Milton Estes, Mill Valley

951282699

Santa Clara Valley Med Ctr, San Jose

06340

Pfizer Central Research, Groton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00002140 - A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients | Biotech Hunter | Biotech Hunter